← Leaderboards
Yu-Wen Alvin Huang
Stanford University
$2,314,330
Attributed
$2,520,912
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $572.1K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,520,912 · 5
By mechanism
R01$762,862 · 1
R00$721,807 · 1
R21$413,164 · 1
R56$385,717 · 1
K99$237,362 · 1
Top collaborators
- David Allenson Borton2 shared
Most similar at Stanford University
Same institution · by research overlap
- Thomas C Sudhof$47,983,108
- Marius Wernig$12,595,017
- Gary K Schoolnik$16,579,521
- Luis De Lecea$21,616,243
- Edward S. Mocarski$11,996,025
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposNeuronsMutantBrainMissionS DiseaseInduced Pluripotent Stem CellElementsUnited States National Institutes Of HealthDisabilityPathogenesisPublic HealthIn VivoInnovationMediatingNeurogliaSignal TransductionPathway InteractionsKnock-OutLightGenotypeGenetic TranscriptionBehavioralAffect
Grant awards (10)
Elucidating the role of CHI3L1/YKL-40 in Alzheimerâs disease$377,285
R01 · FY2025 · AG · contact PI
Elucidating the role of CHI3L1/YKL-40 in Alzheimerâs disease$385,577
R01 · FY2024 · AG · contact PI
Elucidating the role of CHI3L1/YKL-40 in Alzheimer's disease$385,717
R56 · FY2023 · AG · contact PI
Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease$186,371
R21 · FY2023 · AG · contact PI
Bioengineering a cortical microtissue model to study human microglia in Alzheimer's disease$226,793
R21 · FY2022 · AG · contact PI
A Molecular Signaling Pathway Underlying Differential Predisposition of ApoE4 Genotype to Alzheimer's Disease$232,097
R00 · FY2021 · AG · contact PI
A Molecular Signaling Pathway Underlying Differential Predisposition of ApoE4 Genotype to Alzheimer's Disease$240,710
R00 · FY2020 · AG · contact PI
A Molecular Signaling Pathway Underlying Differential Predisposition of ApoE4 Genotype to Alzheimer's Disease$249,000
R00 · FY2019 · AG · contact PI
A molecular signaling pathway underlying differential predisposition of ApoE4 genotype to Alzheimer's disease$118,681
K99 · FY2018 · AG · contact PI
A molecular signaling pathway underlying differential predisposition of ApoE4 genotype to Alzheimer's disease$118,681
K99 · FY2017 · AG · contact PI